A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Charles L. Bowden, Heinz Grunze, Jamie Mullen, Martin Brecher, Björn Paulsson, Martin Jones, Mårten Vågerö, K. Svensson

Research output: Contribution to journalArticlepeer-review

287 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.'. Together they form a unique fingerprint.

Medicine & Life Sciences